What if the brain does not create consciousness?

Christof Koch is taking on one of science’s deepest mysteries: how the brain creates conscious experience, or whether it creates it at all. He argues that materialism has yet to solve this “hard problem” and will explore puzzling phenomena such as near-death experiences and terminal lucidity. His work points toward the possibility that consciousness may be woven into reality itself.

Your dreams aren’t random. Your brain is rewriting reality

Dreams are not random mental noise. A large study of more than 3,700 dream and waking reports found that what we experience during sleep is shaped by both our personalities and the world around us. Rather than simply replaying daily events, the dreaming brain mixes memories, emotions, imagined possibilities, and familiar settings into vivid new scenarios.

Magic mushrooms may reshape the brain long after the trip ends

A single dose of psilocybin produced measurable changes in brain activity and possible changes in brain structure that lasted for up to a month. Participants who experienced the greatest increase in flexible, varied brain activity also reported more personal insight and later improvements in well-being. The findings suggest that the psychedelic experience itself may help people break free from entrenched patterns of thinking.

The mysterious hum heard around the world may finally have an explanation

The mysterious sound known as The Hum has been reported worldwide for decades, yet its source often remains impossible to find. Researchers tested whether people who hear it have exceptional low-frequency hearing or measurable sounds produced inside their ears, but neither explanation fit most participants. The strongest possibility is that many cases involve low-frequency tinnitus, even though the sound seems completely external.

Yale scientists may have found how Parkinson's disease spreads through the brain

Yale scientists discovered two neuron surface proteins that appear to help spread the toxic protein linked to Parkinson’s disease. Blocking these proteins in mice dramatically reduced disease progression, offering a potential new target for future therapies.